Abnormal IgG cardiolipin antibody titers in patients with Raynaud's phenomenon and/or related disorders: prevalence and clinical significance

J Am Acad Dermatol. 1998 Apr;38(4):555-8. doi: 10.1016/s0190-9622(98)70116-1.

Abstract

Background: The prevalence of antibodies to cardiolipin (a-CL) in patients with Raynaud's phenomenon (RP) and/or related disorders (rD) is not known.

Objective: The purpose of this study was to determine the prevalence of these antibodies.

Methods: We assayed IgG a-CL in 230 consecutive patients with RP/rD and compared the results with those in a series of 230 control blood donors.

Results: Sixteen percent of patients were a-CL positive versus 7.8% of the control donors (p = 0.014). The prevalence of a-CL positivity was 8.7% for primary RP, 10.5% for secondary RP, 8% for chilblains, 25% for essential acrocyanosis, 20% for connective tissue diseases, and 17% for undifferentiated connective tissue diseases. Among patients with digital necrosis, 24% were a-CL positive.

Conclusion: The prevalence of abnormal a-CL titers is higher in patients with RP/rD than in control donors, especially in patients with a connective tissue disease.

MeSH terms

  • Antibodies, Anticardiolipin / blood*
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Raynaud Disease / immunology*
  • Seroepidemiologic Studies

Substances

  • Antibodies, Anticardiolipin